SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 392 filers reported holding SEATTLE GENETICS INC in Q1 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $17,698,000 | +6131.7% | 154,893 | +4104.5% | 0.05% | +5200.0% |
| Q3 2018 | $284,000 | -97.2% | 3,684 | -98.1% | 0.00% | -97.0% |
| Q4 2017 | $10,282,000 | +236.5% | 192,187 | +225.4% | 0.03% | +200.0% |
| Q2 2017 | $3,056,000 | -64.4% | 59,056 | -56.7% | 0.01% | -62.1% |
| Q1 2017 | $8,580,000 | -65.3% | 136,498 | -70.9% | 0.03% | -69.5% |
| Q4 2016 | $24,751,000 | +209.2% | 469,039 | +216.5% | 0.10% | +227.6% |
| Q3 2016 | $8,005,000 | +147.5% | 148,209 | +85.2% | 0.03% | +107.1% |
| Q2 2016 | $3,234,000 | +4.5% | 80,021 | +16.1% | 0.01% | -6.7% |
| Q4 2015 | $3,094,000 | +132.5% | 68,949 | +150.7% | 0.02% | +150.0% |
| Q2 2015 | $1,331,000 | -31.3% | 27,500 | -54.4% | 0.01% | -45.5% |
| Q4 2014 | $1,938,000 | -56.8% | 60,310 | -38.8% | 0.01% | -54.2% |
| Q1 2014 | $4,488,000 | +178.2% | 98,502 | +167.6% | 0.02% | +140.0% |
| Q3 2013 | $1,613,000 | -60.5% | 36,811 | -71.7% | 0.01% | -65.5% |
| Q2 2013 | $4,088,000 | – | 129,923 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parametrica Management Ltd | 3,581 | $248,000 | 42.18% |
| Baker Brothers Advisors | 50,057,277 | $3,464,464,000 | 23.54% |
| Lagoda Investment Management, L.P. | 76,073 | $5,265,000 | 6.10% |
| Matrix Capital Management Company, LP | 3,141,852 | $217,448,000 | 4.02% |
| DOMINI IMPACT INVESTMENTS LLC | 3,111 | $215,000 | 2.98% |
| Opus Point Partners Management, LLC | 17,901 | $1,239,000 | 1.83% |
| EMORY UNIVERSITY | 33,593 | $2,325,000 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,215,000 | 1.56% |
| Capital International Sarl | 130,400 | $9,025,000 | 1.26% |
| CAPITAL GUARDIAN TRUST CO | 1,303,961 | $90,147,000 | 1.21% |